SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

Report abuse about a comment

Further comment on dubious study

As I stated a week ago in response to the recently released study on resveratrol, the fault here is with the study design and protocol itself, not the resveratrol used in the study. The dosage used in this study was ridiculously low, compared to all earlier studies. In the case of the successful Albert Einstein Medical School study and the more recent Florida Pharmacology School study the dosages were approximately 10 to 20 times this amount. This dosage is consistent with the supplements used in those trials, specifically biotivia transmax and bioforte, which are readily available without a prescription. Using a dosage of only 75mg was tantamount to giving a heart attack victim one aspirin.

In all previous studies on actual type 2 diabetic patients or those suffering impaired glucose tolerance, a sign of impending diabetes, resveratrol was extremely effective in improving glucose tolerance, enhancing metabolic function and blocking the onset of diabetes.

As a cell biologist who has been involved in several human clinical trials of transmax and bioforte resveratrol against diabetes, I can only imagine that this study was designed by a pharmaceutical company to fail intentionally. The pharmas are clearly aware of the potential of resveratrol to cut into their sales of Metformin, a multi-billion dollar earner for the drug companies, and are on a campaign to discredit the compound.

As a researcher I question why the clinicians in this study would select as subjects women who have no issues with glucose tolerance, who were non-obese, and who did not exhibit signs of diabetes. This is equivalent to testing a compound designed to treat cancer on a group of subjects none of whom has cancer. Again, we see a troubling signal of possible pharma involvement.

Posted by James Betz
01 November 2012 | 08h40

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: Resveratrol study results don’t tell the whole story on benefits: Expert

Spotlight

ABC article says climate change is impacting quality of Chinese tea; whether botanicals in other regions are affected is less clear

ABC article says climate change is impacting quality of Chinese tea; whether botanicals in other regions are affected is less clear

Global climate change is affecting the quality of tea harvested in southwestern China, both in terms of...

Quote/unquote: Gut health, sports nutrition, and curcumin - The best of Bénéfiq 2014

Quote/unquote: Gut health, sports nutrition, and curcumin - The best of Bénéfiq 2014

We headed to Quebec City this week to attend the 2nd instalment of Bénéfiq, an international rendezvous...

Employee ownership key facet of plan to 'reauthenticate' Twinlab, Tolworthy says

Employee ownership key facet of plan to 'reauthenticate' Twinlab, Tolworthy says

Relaunching as an employee-owned company will help focus Twinlab on its mission of “reauthenticating” the brand in...

The most important lessons for doing business in Latin America for dietary supplement companies
Special Edition: LATAM

The most important lessons for doing business in Latin America for dietary supplement companies

Being among the most dynamic regional markets in the world with double-digit growth, and with an increasing...

FTC warns 60 companies for noncompliance on ad disclosure guidelines

FTC warns 60 companies for noncompliance on ad disclosure guidelines

The Federal Trade Commission has sent warning letters to 60 companies, including 20 of the nation’s largest...

In-house manufacturing becoming an important quality differentiator, NOW Foods CEO says

In-house manufacturing becoming an important quality differentiator, NOW Foods CEO says

Consumers are increasingly sensitive to where products are made, and this has helped drive NOW Foods’ expansion...

DPA, vitamins D and K ‘should be investigated’ for cognitive health, says new review

DPA, vitamins D and K ‘should be investigated’ for cognitive health, says new review

A focus on new nutrients, a more holistic approach, and innovative clinical trials using omics technology may...

Ullman on Bayer-FTC issue: ‘Be as careful with your implied claims & testimonials as you are with the express claims’

Ullman on Bayer-FTC issue: ‘Be as careful with your implied claims & testimonials as you are with the express claims’

The US Federal Trade Commission’s motion against Bayer for claims made for its probiotic dietary supplement, Phillips’...

Bayer ‘extremely disappointed & strongly disagrees’ with FTC/DoJ allegations against Phillips’ Colon Health claims

Bayer ‘extremely disappointed & strongly disagrees’ with FTC/DoJ allegations against Phillips’ Colon Health claims

Healthcare giant Bayer has said it will defend itself ‘vigorously’ against the US Federal Trade Commission decision...

GOED confident of success with omega-3 – blood pressure health claim

GOED confident of success with omega-3 – blood pressure health claim

A health claim petition filed by the Global Organization for EPA and DHA Omega-3s (GOED) with the...

Key Industry Events

 

Access all events listing

Our events, Events from partners...